TrimIQ Review (2026): What It Is — and How It Differs From Trimi
TrimIQ is an over-the-counter weight loss supplement that happens to share a similar name with Trimi — but the two are completely unrelated. Here's what TrimIQ contains, what peer-reviewed evidence says about those ingredients, and how an herbal powder differs from clinician-prescribed GLP-1 therapy.
Written by Trimi Medical Team · Medically reviewed by Dr. Sean Arora, MD
More on Comparisons
Important Disclosure
TrimIQ is not affiliated with Trimi in any way — we're reviewing it because the similar name causes real confusion for people searching for us. This article is for informational purposes only and is not medical advice. This review is based on TrimIQ's public materials and published research as of August 2026; we have not tested the product, and we cite no user reviews of it. Talk with a licensed provider before starting or stopping any supplement or medication.
The Direct Answer
TrimIQ is an over-the-counter dietary supplement — a drink powder built around garcinia cambogia, green tea extract, and chromium picolinate, marketed mainly to UK and Ireland customers. It is not affiliated with Trimi, the US telehealth platform for clinician-prescribed compounded GLP-1 therapy, and the two sit in entirely different regulatory and evidence categories.
If you searched "TrimIQ" looking for Trimi's medical weight loss program, you're on the right site — but reading about a different company. If you searched looking for an honest review of the TrimIQ supplement, that's what follows: what it contains, what published research actually shows about those ingredients, and how supplement-scale results compare with prescription therapy. We'll keep it factual and let the evidence speak.
What Is TrimIQ?
TrimIQ launched publicly via an August 2, 2025 GLOBE NEWSWIRE press release announcing its availability in the UK and Ireland. It is sold primarily as a lemon-flavored powder mixed into water, positioned as a "dual-action" formula for weight loss and cognitive support. Per the brand's own FAQ, the core ingredients are garcinia cambogia, green tea extract, chromium picolinate, vitamins B6 and B12, and a probiotic blend.
The marketing is assertive. TrimIQ's UK site has claimed the formula "burns fat 300% faster than diet alone," and its launch press release leans on the phrase "clinically proven ingredients." The brand also advertises a money-back window; check the current terms directly before buying.
One structural point matters before any ingredient discussion: TrimIQ is a dietary supplement. Under the US Dietary Supplement Health and Education Act of 1994, supplements do not require FDA review for safety or effectiveness before they are marketed. That is not a criticism of TrimIQ specifically — it is the rulebook for the entire supplement category, and it is why supplement claims and prescription-drug evidence should never be compared as if they were the same kind of statement.
What the Evidence Says About TrimIQ's Ingredients
There is no published, peer-reviewed clinical trial of the TrimIQ formula itself that we could locate as of August 2026 — not in PubMed and not in major trial registries. That is common for supplements. What we can do is look at the best available evidence for each ingredient, which comes from systematic reviews and meta-analyses that pool every qualifying randomized trial.
| Ingredient | Marketed role | What peer-reviewed evidence shows |
|---|---|---|
| Garcinia cambogia (HCA) | Appetite reduction, "fat blocking" | A 2011 Journal of Obesity meta-analysis of 9 randomized trials found −0.88 kg (under 2 lb) vs placebo over short trials; the authors rated most studies methodologically poor |
| Green tea extract | Metabolism, thermogenesis | The 2012 Cochrane review (14 trials) found a small, statistically non-significant weight loss not likely to be clinically important; in studies conducted outside Japan the difference was −0.04 kg |
| Chromium picolinate | Cravings, blood sugar support | A 2013 Obesity Reviews meta-analysis of 11 trials found −0.50 kg vs placebo; the authors called the effect small and its clinical relevance uncertain |
| Vitamins B6 and B12 | Energy, focus | Support normal energy metabolism; no evidence they cause weight loss in people who are not deficient |
| Probiotic blend | Digestion, gut health | Effects are strain-specific and mixed across studies; no established weight loss effect at typical supplement doses |
The most-cited of these is the garcinia analysis. According to the 2011 Journal of Obesity meta-analysis by Onakpoya and colleagues, the pooled difference versus placebo was 0.88 kg — with a confidence interval that reached all the way to zero — and the authors cautioned that short durations and poor trial quality prevented firm conclusions. The Cochrane Collaboration's verdict on green tea was similarly restrained:
The 2012 Cochrane review concluded that green tea preparations induce a small, statistically non-significant weight loss in overweight or obese adults — and because the amount lost is small, "it is not likely to be clinically important."
Add the three headline ingredients together generously and the published evidence supports somewhere around one to three pounds of short-term difference versus placebo. That is not nothing — but it is the honest scale of the category. Individual results vary.
About the 23% metabolic-rate claim
TrimIQ's marketing has claimed a 23% average increase in resting metabolic rate within four weeks. A quantified product claim like that would normally require a controlled trial of the product itself to substantiate — the FTC's health products guidance calls for competent and reliable scientific evidence behind claims of this kind. As of our research date, we could not locate a published trial of the TrimIQ formula testing that figure, and the ingredient-level meta-analyses above measure modest, single-digit-pound differences in weight, not large metabolic shifts.
To be fair to the brand: "clinically studied ingredients" is technically accurate. Garcinia, green tea extract, and chromium have all been studied extensively. The studies simply found small effects. That distinction — studied versus proven effective at a meaningful scale — is the single most useful lens for reading any supplement label.
If supplements haven't moved the needle
There's an evidence-backed next step
Many people try herbal formulas first and are frustrated by one-to-two-pound results. Prescription GLP-1 therapy is the category with large randomized trials behind it; a licensed provider determines whether it is appropriate for you. Through Trimi, compounded semaglutide is $99/mo and tirzepatide is $125/mo on the annual plan, backed by a 6-month money-back policy. Individual results vary.
Start your online visitSupplement vs Prescription GLP-1 Therapy: Different Categories Entirely
The comparison people actually want to make — "should I buy TrimIQ or look into GLP-1s?" — is really a comparison between two regulatory and evidence categories, not two products.
Prescription GLP-1 medicines have been through large randomized controlled trials. According to the STEP 1 trial published in the New England Journal of Medicine in 2021, adults taking semaglutide 2.4 mg weekly lost a mean of 14.9% of body weight at 68 weeks, versus 2.4% with placebo. According to the SURMOUNT-1 trial in the same journal in 2022, tirzepatide produced up to 20.9% mean weight loss at 72 weeks at the highest dose studied. Individual results vary, and trial participants also received lifestyle counseling.
| TrimIQ (supplement) | Clinician-prescribed GLP-1 therapy | |
|---|---|---|
| Regulatory category | Dietary supplement (DSHEA); no FDA review for effectiveness before sale | Prescription therapy under licensed-provider supervision |
| Best supporting evidence | Ingredient-level meta-analyses: roughly 0-2 lb difference vs placebo per ingredient, short-term | Large randomized trials of FDA-approved GLP-1 medicines: 14.9% mean loss (STEP 1, semaglutide 2.4 mg); up to 20.9% (SURMOUNT-1, tirzepatide) |
| Medical oversight | None; self-directed purchase | Provider evaluation, prescription, dose titration, ongoing follow-up |
| Side-effect profile | Caffeine effects from green tea extract; rare liver-injury case reports with garcinia | Nausea, vomiting, diarrhea, constipation are common, especially during titration; labels carry additional warnings |
| Cost through Trimi | Varies by bundle at TrimIQ's site | $99/mo semaglutide, $125/mo tirzepatide (annual plan), all-inclusive |
Trial figures describe semaglutide 2.4 mg and tirzepatide as studied in the STEP 1 and SURMOUNT-1 brand-drug trials. Trimi's compounded preparations are prepared per individual prescription by a state-licensed pharmacy — VialsRx (Texas license #35264) or GreenwichRx — and are not FDA-approved as drugs. Individual results vary.
The oversight column deserves emphasis. Per FDA prescribing information, GLP-1 medicines commonly cause gastrointestinal side effects — nausea, vomiting, diarrhea, constipation — particularly while doses are being increased, and their labels carry additional warnings. That risk profile is exactly why they are prescription products: a licensed provider determines whether therapy is appropriate for you, sets the titration schedule, and stays available when something feels off. Real efficacy and real oversight travel together.
If you want to see how that model works in practice, our compounded semaglutide and compounded tirzepatide pages walk through the clinical evidence and program details, and the cost guide breaks down exactly what membership covers. For how Trimi stacks up against other telehealth programs rather than supplements, see our Calibrate vs Found vs Trimi comparison.
Where supplements do fit
None of this means every supplement is pointless. Protein powders, collagen, and targeted micronutrients can play a genuine supporting role — particularly for people on GLP-1 therapy working to preserve lean mass while eating less. We cover that use case in our guide to the best collagen for GLP-1 users. The distinction is between supplements as support and herbal blends marketed as a substitute for treatments with trial-grade evidence. The published data does not support the substitute role.
Frequently Asked Questions
Is TrimIQ the same as Trimi?
No. TrimIQ is an over-the-counter dietary supplement brand — a drink powder built around garcinia cambogia, green tea extract, and chromium picolinate, sold primarily to UK and Ireland customers. Trimi (trytrimi.com) is a US telehealth platform where licensed providers evaluate patients and, when appropriate, prescribe compounded GLP-1 medications dispensed by state-licensed pharmacies. The two companies are not affiliated in any way, share no ownership, and sell entirely different categories of product. The similar names are a coincidence.
Does TrimIQ work for weight loss?
As of August 2026, we could not locate any published, peer-reviewed clinical trial of the TrimIQ formula itself. The evidence that exists covers its individual ingredients, and it points to small effects: a 2011 Journal of Obesity meta-analysis found garcinia cambogia produced about 0.88 kg (under 2 lb) more short-term weight loss than placebo, from mostly low-quality trials; a 2012 Cochrane review concluded green tea produced a small, statistically non-significant weight loss that is not likely to be clinically important; and a 2013 Obesity Reviews meta-analysis put chromium's effect at about 0.5 kg with uncertain clinical relevance. Individual results vary.
How does TrimIQ compare with GLP-1 medications?
They are different categories. TrimIQ is a dietary supplement, which under US law is not reviewed by the FDA for effectiveness before it is sold. Prescription GLP-1 medicines have been tested in large randomized trials: in the STEP 1 trial (NEJM 2021), semaglutide 2.4 mg produced 14.9% mean body-weight loss at 68 weeks versus 2.4% with placebo, and in SURMOUNT-1 (NEJM 2022), tirzepatide produced up to 20.9% at 72 weeks. Ingredient-level supplement evidence measures differences in single-digit pounds. GLP-1 therapy requires a prescription, carries real side effects such as nausea and other GI symptoms, and needs clinical oversight. Individual results vary.
Is TrimIQ safe?
Its listed ingredients are common in supplements at typical doses, but a few cautions apply. Green tea extract naturally contains caffeine, so caffeine-sensitive users should take care. Garcinia cambogia has been associated with isolated case reports of liver injury, generally at high doses or in multi-ingredient products. Supplements are not FDA-reviewed for safety or effectiveness before marketing, so quality varies by manufacturer. If you are pregnant, nursing, take prescription medication, or have a medical condition, talk with a licensed provider before starting any weight loss supplement.
Does Trimi sell or endorse TrimIQ?
No. Trimi has no relationship with TrimIQ and does not sell dietary supplements. Trimi's model is clinical: a licensed provider reviews your health history, decides whether GLP-1 therapy is appropriate, and if so prescribes compounded semaglutide or tirzepatide prepared per individual prescription by a state-licensed pharmacy — VialsRx (Texas license #35264) or GreenwichRx. Compounded preparations are not FDA-approved as drugs. Membership is $99/month for semaglutide or $125/month for tirzepatide on the annual plan, backed by a 6-month money-back policy.
Ready for the Evidence-Backed Path?
A licensed provider reviews your health history and determines whether GLP-1 therapy is right for you. Compounded semaglutide $99/mo, tirzepatide $125/mo on the annual plan — free overnight shipping once compounded, 6-month money-back policy. Individual results vary.
Start your online visitSources & References
- GLOBE NEWSWIRE. "TrimIQ Weight Loss: Official launched in UK and Ireland With Green Tea Probiotic Complex." August 2, 2025.
- Onakpoya I, et al. The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. Journal of Obesity. 2011;2011:509038.
- Jurgens TM, et al. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database of Systematic Reviews. 2012;(12):CD008650.
- Onakpoya I, et al. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obesity Reviews. 2013;14(6):496-507.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
- U.S. Food & Drug Administration. Dietary Supplements — regulatory overview under the Dietary Supplement Health and Education Act of 1994.
- Federal Trade Commission. Health Products Compliance Guidance. 2022.
- FDA Prescribing Information, semaglutide and tirzepatide injection products — Adverse Reactions sections.